These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Bukhatwa S; Zeng BY; Rose S; Jenner P Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003 [TBL] [Abstract][Full Text] [Related]
5. Functional mapping in PD and PSP for sustained phonation and phoneme tasks. Sachin S; Senthil Kumaran S; Singh S; Goyal V; Shukla G; Mahajan H; Behari M J Neurol Sci; 2008 Oct; 273(1-2):51-6. PubMed ID: 18675995 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation. Murthy M; Fodder K; Miki Y; Rambarack N; De Pablo Fernandez E; Pihlstrøm L; Mill J; Warner TT; Lashley T; Bettencourt C Acta Neuropathol; 2024 Jul; 148(1):4. PubMed ID: 38995454 [TBL] [Abstract][Full Text] [Related]
7. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. Yekhlef F; Ballan G; Macia F; Delmer O; Sourgen C; Tison F J Neural Transm (Vienna); 2003 Feb; 110(2):151-69. PubMed ID: 12589575 [TBL] [Abstract][Full Text] [Related]
9. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy. Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321 [TBL] [Abstract][Full Text] [Related]
10. Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study. Gama RL; Távora DG; Bomfim RC; Silva CE; de Bruin VM; de Bruin PF Parkinsonism Relat Disord; 2010 May; 16(4):275-9. PubMed ID: 20185356 [TBL] [Abstract][Full Text] [Related]
11. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. Nicoletti G; Rizzo G; Barbagallo G; Tonon C; Condino F; Manners D; Messina D; Testa C; Arabia G; Gambardella A; Lodi R; Quattrone A Radiology; 2013 Jun; 267(3):843-50. PubMed ID: 23329659 [TBL] [Abstract][Full Text] [Related]
12. White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study. Zanigni S; Evangelisti S; Testa C; Manners DN; Calandra-Buonaura G; Guarino M; Gabellini A; Gramegna LL; Giannini G; Sambati L; Cortelli P; Lodi R; Tonon C Parkinsonism Relat Disord; 2017 Jun; 39():44-51. PubMed ID: 28291592 [TBL] [Abstract][Full Text] [Related]
13. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785 [TBL] [Abstract][Full Text] [Related]
14. Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy. Surova Y; Nilsson M; Lätt J; Lampinen B; Lindberg O; Hall S; Widner H; Nilsson C; van Westen D; Hansson O Neuroradiology; 2015 Nov; 57(11):1079-91. PubMed ID: 26253801 [TBL] [Abstract][Full Text] [Related]
15. Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Cosottini M; Ceravolo R; Faggioni L; Lazzarotti G; Michelassi MC; Bonuccelli U; Murri L; Bartolozzi C Acta Neurol Scand; 2007 Jul; 116(1):37-42. PubMed ID: 17587253 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy. Reginold W; Lang AE; Marras C; Heyn C; Alharbi M; Mikulis DJ Parkinsonism Relat Disord; 2014 Feb; 20(2):222-5. PubMed ID: 24239142 [TBL] [Abstract][Full Text] [Related]
17. New and reliable MRI diagnosis for progressive supranuclear palsy. Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570 [TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879 [TBL] [Abstract][Full Text] [Related]
19. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy]. Yoshita M; Hayashi M; Hirai S Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173 [TBL] [Abstract][Full Text] [Related]
20. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy. Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]